Pascal Touchon, President and CEO at Atara Biotherapeutics, Inc. (ATRA), sold 20,409 shares at $0.39 ($8K) on 2023-11-16, disclosed to the SEC on 2023-11-20.
Seasonal sale ($8k) by President and CEO — this insider has traded ATRA in November in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| ATRA | SELL | 2024-03-06 | $18K | — | Filing → |
| ATRA | SELL | 2023-08-18 | $51K | — | Filing → |
| ATRA | SELL | 2023-06-29 | $24K | — | Filing → |